Complete Blood Count (CBC) Analyzers and Reagents

SOL #: W81K0426QA025Solicitation

Overview

Buyer

DEPT OF DEFENSE
Dept Of The Army
W40M MRCO EAST
FORT BELVOIR, VA, 22060-5580, United States

Place of Performance

Fort Bragg, NC

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Jan 29, 2026
2
Last Updated
Feb 19, 2026
3
Submission Deadline
Feb 20, 2026, 5:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of the Army, Bragg Services Branch, is soliciting proposals for Complete Blood Count (CBC) Analyzers and Reagents on a Cost per Reportable Result (CPRR) basis. This Firm-Fixed Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract requires non-personal services, equipment, and supplies to support hematology automation systems at Womack Army Medical Center, Clark Health Clinic, and Robinson Health Clinic at Fort Bragg, NC. Proposals are due February 20, 2026, at 12:00 PM EST.

Scope of Work

The contractor shall provide all necessary reagents, testing systems, equipment, personnel, transportation, materials, supervision, maintenance, and training. This includes two automated CBC analytical systems, one slide maker/stainer, and one digital cell imager for Womack Army Medical Center. Additionally, two identical automated CBC analytical systems are required, one each for Clark Health Clinic and Robinson Health Clinic. All analyzers will operate on a CPRR basis. Equipment and reagents must be FDA approved for clinical use, new, and capable of interfacing with the MHS Genesis system. Comprehensive support, including training, maintenance, and quality control materials, is also required.

Contract Details

  • Solicitation Number: W81K0426QA025
  • Contract Type: Firm-Fixed Price (FFP) IDIQ
  • Set-Aside: Full and Open (Unrestricted)
  • NAICS Code: 325413, In-Vitro Diagnostic Substance Manufacturing
  • PSC: 6550, In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
  • Period of Performance: The delivery period is from April 1, 2026, through March 31, 2031, following a validation period from March 1, 2026, through March 31, 2026.

Submission & Evaluation

Offerors must submit proposals by February 20, 2026, at 12:00 PM EST. Submissions should include administrative information, past performance references (using Attachment 2), technical capability details, and pricing (using Attachment 3 - Cost Per Reportable Pricing Worksheet). Evaluation will be based on Technical Capability (acceptable/unacceptable), Past Performance (acceptable/unacceptable), and Price. Award will be made to the responsible offeror with the lowest price determined acceptable for technical and past performance factors.

Amendments & Attachments

This solicitation has been amended. Key changes to the Statement of Work (SOW) include the removal of sections 2.11, 4.16, and 10 ("Additional Requirements"), revision of section 4.15, and addition of section 5.11. All other terms and conditions remain unchanged, and the quotes due date will not be extended. Offerors must refer to Attachment 1 (Amended) for the updated SOW and all provisions and clauses.

People

Points of Contact

Victoria ManigaultPRIMARY

Files

Files

Download
Download
Download

Versions

Version 4
Solicitation
Posted: Feb 19, 2026
View
Version 3Viewing
Solicitation
Posted: Feb 11, 2026
Version 2
Solicitation
Posted: Feb 2, 2026
View
Version 1
Pre-Solicitation
Posted: Jan 29, 2026
View
Complete Blood Count (CBC) Analyzers and Reagents | GovScope